X0306 4 2019-02-19 0 0000891293 CTI BIOPHARMA CORP ctic 0001276750 KIRSKE DAVID C/O CTI BIOPHARMA CORP. 3101 WESTERN AVE., SUITE 800 SEATTLE WA 98121 0 1 0 0 EVP, Chief Financial Officer Non-Qualified Stock Option (right to buy) 0.9489 2019-02-19 4 A 0 500000 0 A 2029-02-19 Common Stock 500000 500000 D 1/3 of the shares subject to the Option shall vest on the one year anniversary of February 19, 2019, and 1/3 of the shares shall vest annually thereafter on February 19, subject to Reporting Person continuing to be an employee or service provider on each date, such that the Option shall be fully vested on February 19, 2022. David H. Kirske 2019-02-19